The Indian Challenge: The Evolution of a Successful New Global Strategy in the Pharmaceutical Industry

Authors: Bower, D. Jane¹; Sulej, Julian C.¹

Source: Technology Analysis and Strategic Management, Volume 19, Number 5, September 2007 , pp. 611-624(14)

Publisher: Routledge, part of the Taylor & Francis Group

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

UK and European public policy has sought to encourage young biotechnology firms adopt American-inspired strategies. The venture-backed start-up associated with Silicon Valley and Route 128 in Boston, has been the preferred model. These policies have had limited success thus far. Indian companies are evolving indigenous business models that are achieving success within the pharmaceutical industry. Some Indian pharmaceutical firms, established initially as low cost suppliers, are investing in building innovative capabilities. This paper analyses the strategies and trajectories of a number of Indian pharmaceutical companies that are expanding successfully in Western markets. It assesses the local and international contextual factors that have underpinned the strategies and discusses relevant conceptual frameworks.

Document Type: Research article

DOI: 10.1080/09537320701521358

Affiliations: 1: Centre for Enterprise Management, University of Dundee, Scotland, UK

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$38.34 plus tax Refund Policy